Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue-Reference-Cited by-同舟云学术

Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue

Published:2015-07-02 Issue:1 Volume:3 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Lemoine Laetitia,Saint-Aubert Laure,Marutle Amelia,Antoni Gunnar,Eriksson Jonas P,Ghetti Bernardino,Okamura Nobuyuki,Nennesmo Inger,Gillberg Per-Göran,Nordberg Agneta

Funder

swedish medical research council

swedish brain power

Regional agreement of medical training and clinical research (ALF)for Stockholm county council

The strategic research programme in Neuroscience at Karolinska Institutet

The foundation for old servants

Gun and Bertil Stohnes foundation

Hjärnfonden

Alzheimer foundation

EU FW7 large scale integrated INMIND

Stiftelsen för Strategisk Forskning

Kentucky Space Grant Consortium

Demensfonden

Goljes Minne

Tore Nilsson foundation

Foundation of aging diseases

KI foundations

GE Healthcare

Wenner-Gren Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-015-0220-4.pdf

Reference27 articles.

1. Nordberg A (2010) Amyloid imaging in early detection of Alzheimer’s disease. Neurodegener Dis 7:136–138. doi:10.1159/000289223

2. Seppala TT, Nerg O, Koivisto AM, Rummukainen J, Puli L, Zetterberg H, Pyykko OT, Helisalmi S, Alafuzoff I, Hiltunen M et al (2012) CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78:1568–1575. doi:10.1212/WNL.0b013e3182563bd0

3. Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60:652–656

4. Zetterberg H, Lautner R, Skillback T, Rosen C, Shahim P, Mattsson N, Blennow K (2014) CSF in Alzheimer’s disease. Adv Clin Chem 65:143–172

5. Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC (2015) Tau imaging: early progress and future directions. The Lancet Neurology 14:114–124. doi:10.1016/S1474-4422(14)70252-2

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A closer look at amyloid ligands, and what they tell us about protein aggregates;Chemical Society Reviews;2024

2. Biological Applications of Autoradiography: Present and Future;PROG BIOCHEM BIOPHYS;2023

3. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET;Biomolecules;2023-02-03

4. Discovery and evaluation of aza-fused tricyclic derivatives for detection of Tau pathology in Alzheimer's disease;European Journal of Medicinal Chemistry;2023-01

5. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains;Molecular Psychiatry;2022-11-29